Clinical Trial

DELirium, Incidence, preVEntion and pRogression During Acute Intensive Neurological -Neurosurgical Rehabilitation

Study acronym: DeliVeriNN
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
In this longitudinal cohort study the incidence of delirium is assessed for all patients being admitted to the acute intensive neurological-neurosurgical rehabilitation over 3 years. Delirium assessment will be performed daily from admission to discharge. Patients will be divided into 3 groups, according to the presentation of delirium on admission, during the course or not any during the stay in acute rehabilitation and compared regarding the treatment and outcome.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-16.
Trial Details
NCT Number NCT07070310
Lead Sponsor Heart Centre Rotenburg
Conditions Neurological Conditions
Enrollment 210 participants
Start Date 2025-08-15
Primary Completion 2028-08-15 (estimated)
Study Completion 2029-02-15 (estimated)
Updated on ClinicalTrials.gov 2025-07-22